Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UVADEX ECP in Refractory Rheumatoid Arthritis
NCT00221000Phase 2Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Aug 2003
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of methoxsalen in rheumatoid arthritis (RA), sponsored by Mallinckrodt Pharmaceuticals. Started Aug 2003; status: completed.
02
Drugs
methoxsalen
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00221000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221000.